RxDoctor Payments Data

Danielle Westrick, MD

Family Medicine · Glandorf, OHNPI 1629311311

Payments from drug & device makers

$463in general payments, 2019–2025

Across 26 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$86
  • Novo Nordisk$66
  • AbbVie$59
  • Dexcom, Inc.$39
  • Lilly USA, LLC$39
  • Bayer$34
  • plus $140 from 7 others

What the payments were for

  • Food & beverage$463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$463 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$144,090
Medicare patients
374
Services billed
2,248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban306$157,689
Avonex Pen (4 Pack)Interferon Beta-1a14$116,311
JardianceEmpagliflozin157$103,910
OzempicSemaglutide85$91,469
JanuviaSitagliptin Phosphate127$77,187
XareltoRivaroxaban109$65,197
TradjentaLinagliptin221$61,029
Invega SustennaPaliperidone Palmitate16$59,214
MounjaroTirzepatide28$30,947
TrulicityDulaglutide28$28,049
AptiomEslicarbazepine Acetate21$26,894
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$25,382
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog86$23,043
JanumetSitagliptin Phos/Metformin Hcl22$18,896
Spiriva RespimatTiotropium Bromide19$15,120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Paxlovid$14$176,154360 claims
Novo NordiskOzempic$66$91,46985 claims
Lilly USA, LLCMounjaro, Trulicity$39$58,99656 claims
AstraZenecaFarxiga, Brilinta, Breztri Aerosphere$19$32,66677 claims
GSKTrelegy Ellipta$14$25,38238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Glandorf

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →